Cell to Sell - Commercialization of BioProducts

"Cell to Sell" is a term that refers to OBIC's market-pull model in which we connect a company's bio-based innovation to industrial collaborators across a product supply chain and research collaborators to address technical gaps. Ohio has a strong industry network represented, in part, by our OBIC Board of advisors. Expertise across a large and growing list of research collaborators assures scientific support as needed by the project. Supportive public policies in Ohio help catalyze these investments. All of these resources come together in the "Cell to Sell" innovation pipeline. http://bioproducts.osu.edu/index.php/news-room/108-what-is-cell-to-sell